Cellular senescence and frailty: a comprehensive insight into the causal links.
Serena MarcozziGiorgia BigossiMaria Elisa GiulianiRobertina GiacconiFrancesco PiacenzaMaurizio CardelliDario BrunettiAgnese SegalaAlessandra ValerioEnzo NisoliFabrizia LattanzioMauro ProvincialiMarco MalavoltaPublished in: GeroScience (2023)
Senescent cells may have a prominent role in driving inflammation and frailty. The impact of cellular senescence on frailty varies depending on the assessment tool used, as it is influenced by the criteria or items predominantly affected by senescent cells and the varying weights assigned to these items across different health domains. To address this challenge, we undertook a thorough review of all available studies involving gain- or loss-of-function experiments as well as interventions targeting senescent cells, focusing our attention on those studies that examined outcomes based on the individual frailty phenotype criteria or specific items used to calculate two humans (35 and 70 items) and one mouse (31 items) frailty indexes. Based on the calculation of a simple "evidence score," we found that the burden of senescent cells related to musculoskeletal and cerebral health has the strongest causal link to frailty. We deem that insight into these mechanisms may not only contribute to clarifying the role of cellular senescence in frailty but could additionally provide multiple therapeutic opportunities to help the future development of a desirable personalized therapy in these extremely heterogeneous patients.
Keyphrases
- induced apoptosis
- cell cycle arrest
- community dwelling
- public health
- healthcare
- dna damage
- oxidative stress
- endoplasmic reticulum stress
- endothelial cells
- cell death
- stem cells
- end stage renal disease
- risk assessment
- newly diagnosed
- signaling pathway
- type diabetes
- metabolic syndrome
- social media
- risk factors
- pi k akt
- mesenchymal stem cells
- stress induced
- drug induced